Original article
Effects of cardiac rehabilitation on obese hypertensive patients: A controlled trial
Efectos de la rehabilitación cardíaca en pacientes hipertensos obesos: un ensayo controlado
Share
ISSN: 1889-1837
Hipertensión y Riesgo Vascular ha recibido Factor de Impacto (JCR) por primera vez en 2023.
Guía para autores
-
Envío de manuscritos
Indexed in:
Web of Science, Index Medicus/MEDLINE, SCOPUS, IBECS, IME
See moreFollow us:
Subscribe:
Impact factor
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2022
Impact factor 2022
0.6
Citescore 2022
1.3
SJR
SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.
See moreSJR 2022
0.163
SNIP
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
See moreSNIP 2022
0.26
View more metrics
Hide
Journal Information
Publish in
Hipertensión y Riesgo Vascular
Special content about COVID-19
- Type 2 diabetes patients requiring empagliflozin in Southeast of Iran: Frequency and guideline adherence (2022–2023)
- Cefalea e hipertensión como forma de presentación de un feocromocitoma y simulando un síndrome post-COVID-19
- Counteracting aldosterone in cardiorenal disease in type 2 diabetes through finerenone administration
- Niveles plasmáticos de troponina T y de la fracción aminoterminal del propéptido natriurético cerebral y su relación con mortalidad en COVID-19
Free access articles
Hipertens Riesgo Vasc. 2023;40:75-84
Hipertens Riesgo Vasc. 2022;39:174-94
Hipertens Riesgo Vasc. 2022;39:69-78